Note: Ingredients listed on restricted chemical lists
EC/CAS
100-42-5
Name of the chemical
Styrene ( Vinyl benzene )
Concentration
N/A
EC/CAS
80-62-6
Name of the chemical
methacrylic acid, methyl ester
Concentration
N/A
EC/CAS
25973-55-1
Name of the chemical
2-(2H-benzotriazol-2-yl)-4,6-ditertpentylphenol (UV-328)
Concentration
N/A
General Information
Revision date
2010-01-13
Product name
748397222UPR 3200LB TOTE
supplier name
100 Cottage Place
Emergency telephone
(703) 527-3887
Icons in SDS
Company Information
company name
Hexion Specialty Chemicals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
4information@hexion.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Form Viscous liquid. Odor Styrene OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING ! FLAMMABLE LIQUID AND VAPOR. MAY FORM EXPLOSIVE MIXTURES WITH AIR. INHALATION CAUSES HEADACHES, DIZZINESS, DROWSINESS AND NAUSEA AND MAY LEAD TO UNCONSCIOUSNESS. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION.
Potential Acute Health Effects
Inhalation Can cause central nervous system (CNS) depression. Irritating to respiratory system. Ingestion Can cause central nervous system (CNS) depression. Skin Irritating to skin. May cause sensitization by skin contact. Eyes Irritating to eyes.
Potential chronic health
effects Contains material that can cause target organ damage. Can cause neurotoxicity. Carcinogenicity Contains material which may cause cancer, based on animal data. Risk of cancer depends on duration and level of exposure. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which causes damage to the following organs: peripheral nervous system, upper respiratory tract, eyes, central nervous system (CNS), ears Review Section 2 and 11 for any additional assessments. Over-exposure signs/symptoms Inhalation Adverse symptoms may include the following: nausea or vomiting, respiratory tract irritation, coughing, headache, drowsiness/fatigue, dizziness/vertigo, unconsciousness, irritability, convulsion, confusion, weakness, tremor, excitability, lack of coordination depression Ingestion Adverse symptoms may include the following: nausea or vomiting, dizziness/vertigo, drowsiness/fatigue, headache, unconsciousness, Skin Adverse symptoms may include the following: irritation, redness, Eyes Adverse symptoms may include the following: pain or irritation, watering, redness,
Medical Conditions Generally Aggravated by Exposure
Pre-existing skin disorders and disorders involving any other target by over-exposure organs mentioned in this MSDS as being at risk may be aggravated by over-exposure to this product. See section 11 for more detailed information on health effects and symptoms.
